Progyny (NASDAQ: PGNY) reported Q2 EPS of $0.48, $0.32 better than the analyst estimate of $0.16. Revenue for the quarter came in at $332.84 million versus the consensus estimate of $317.61 million.

GUIDANCE:

Progyny sees Q3 2025 EPS of $0.37-$0.40, versus the consensus of $0.36. Progyny sees Q3 2025 revenue of $290-305 million, versus the consensus of $292.3 million.

Progyny sees FY2025 EPS of $1.70-$1.78, versus the consensus of $1.63. Progyny sees FY2025 revenue of $1.23-1.27 billion, versus the consensus of $1.23 billion.

For earnings history and earnings-related data on Progyny (PGNY) click here.